IART 240920 25.00C (IART240920C25000) Stock Options, News & Quotes

US OptionsDetailed Quotes

IART240920C25000

Watchlist

0.25
+0.07+38.89%

15min DelayClose Aug 23 16:00 ET

0.25High0.25Low

Intraday

5D
Daily

News

Bullish Integra LifeSciences Holdings Insiders Loaded Up On US$2.50m Of Stock
Simply Wall StAug 23 07:28 ET
Integra LifeSciences Is Maintained at Sell by Citigroup
Dow JonesAug 22 12:02 ET
Expert Outlook: Integra Lifesciences Through The Eyes Of 8 Analysts
BenzingaAug 22 12:00 ET
Express News | Integra Lifesciences Holdings Corp : Citigroup Cuts Target Price to $20 From $23
ReutersAug 22 06:45 ET
Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Cuts Target Price to $20
Moomoo NewsAug 22 06:31 ET · Ratings
Integra LifeSciences Continues to Make Progress on Its ESG Strategy
GlobeNewswireAug 21 16:15 ET

Comments

Money Mover

Jul 1 10:35

Going to miss guidance/earnings

$Integra Lifesciences (IART.US)$ its a buy at $24

Money Mover

Jun 27 14:20

$Integra Lifesciences (IART.US)$ Integra LifeSciences Price Target Cut to $25.00/Share From $45.00 by Wells Fargo

Moomoo AI

Feb 11 08:35

EPS growth doesn't align with share price, indicating it may not reflect business performance or growth expectations may have been high. Integra LifeSciences Holdings' performance led to a 3% annual loss for shareholders over five years. Investors should note 3 warning signs.

While Shareholders of Integra LifeSciences Holdings (NASDAQ:IART) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Moomoo AI

Jan 29 04:30

Insider transactions suggest a positive outlook for Integra LifeSciences Holdings, with insiders net buying the stock. The level of insider ownership indicates a reasonable degree of alignment with shareholder interests.

Several Insiders Invested In Integra LifeSciences Holdings Flagging Positive News

Moomoo AI

Jan 15 05:36

Integra LifeSciences Holdings trades at a low price, suggesting a buying opportunity. Higher cash flow is expected, potentially boosting share valuation. The positive outlook seems not fully factored into the share price, indicating it's not too late to buy IART.

At US$42.94, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?